Please login to the form below

Not currently logged in
Email:
Password:

Ritter Pharmaceuticals appoints new CMO

AnnKatrin Petersen-Jappelli to strengthen company

Ritter Pharmaceuticals has appointed AnnKatrin Petersen-Jappelli as chief medical officer.

Ritter is currently developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases.

Michael Step, CEO of Ritter Pharmaceuticals, said: “The additions of Dr Petersen-Jappelli further strengthens Ritter Pharmaceuticals' management with a leader who has significant experience in both the biotech and pharmaceutical industries, with a focus on treating gastrointestinal diseases.

Petersen-Jappelli joins Ritter having spent over 25 years in the pharmaceutical and biotechnology industry. Before this she served at Santarus as scientific research and clinical development leader of a phase III program for traveler's diarrhoea.

She said: “Joining Ritter Pharmaceuticals is an exciting opportunity to be part of a unique and innovative company that is working to treat gastrointestinal disease through the modulation of the gut microbiome.

“I believe my experience in product development coupled with my research capabilities will be a great combination for this role and I look forward to working with the team as we advance our science, build our product portfolio, and bring therapeutics to market that have the potential to provide significant relief to patients suffering from gastrointestinal diseases.”

9th October 2015

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics